{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:08:12Z","timestamp":1768687692777,"version":"3.49.0"},"reference-count":80,"publisher":"Informa UK Limited","issue":"15","funder":[{"name":"the Medical University of Lodz, Poland"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2020,10,12]]},"DOI":"10.1080\/14656566.2020.1791083","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T15:13:12Z","timestamp":1595257992000},"page":"1915-1926","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of idelalisib for the treatment of indolent B-cell malignancies"],"prefix":"10.1080","volume":"21","author":[{"given":"Piotr","family":"Smolewski","sequence":"first","affiliation":[{"name":"Department of Experimental Hematology, Medical University of Lodz, Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominika","family":"Rydygier","sequence":"additional","affiliation":[{"name":"Department of Experimental Hematology, Medical University of Lodz, Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-535047"},{"key":"cit0002","first-page":"64","volume":"14","author":"Porta C","year":"2014","journal-title":"Front Oncol"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0778-4"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1038\/nri1056"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2882"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1400055"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-271171"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-018-0001-1"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1177\/2040620714561581"},{"key":"cit0010","doi-asserted-by":"crossref","unstructured":"Zirlik K, Veelken H. Idelalisib. Recent Results Cancer Res. 2018;212:243-264.","DOI":"10.1007\/978-3-319-91439-8_12"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00256"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2003.07.007"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0304-0"},{"key":"cit0014","unstructured":"CHMP. Zydelig, INN-Idelalisib; 2016. [cited 2020 Mar 20]. Available from: www.ema.europa.eu\/contact."},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315226"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-352492"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-275305"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.1774.1774"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-538546"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.2744.2744"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2522"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.1543.1543"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-537555"},{"key":"cit0025","unstructured":"Zydelig Approval History [cited May 2020]. Available from: https:\/\/www.drugs.com\/history\/zydelig.html"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01460"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30028-5"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-633156"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-12-683516"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30019-4"},{"key":"cit0031","doi-asserted-by":"crossref","unstructured":"Zelenetz A, Barrientos J, Brown J, et al. Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2017;18:297\u2013311.","DOI":"10.1016\/S1470-2045(16)30671-4"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000039"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1022770"},{"key":"cit0034","unstructured":"CHMP. Zydelig, INN-Idelalisib. 2016. [cited 2020 Mar 20]. Available from: www.ema.europa.eu\/contact."},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.151738"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-707133"},{"key":"cit0037","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood.V130.Suppl_1.SCI-39.SCI-39","volume":"130","author":"Brown JR","year":"2017","journal-title":"Blood"},{"key":"cit0038","unstructured":"HIGHLIGHTS OF PRESCRIBING INFORMATION. [cited 2020 Mar 20]. Available from: www.fda.gov\/medwatch."},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2540"},{"key":"cit0040","first-page":"195","volume":"128","author":"Haustraete E","year":"2016","journal-title":"Eur Respir J"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2018.1516184"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.3705.3705"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1820-0"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000522"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.164103"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000525"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.04.132"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-702761"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0474"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2693-z"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw672"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1070"},{"key":"cit0053","unstructured":"Food and Drug Administration. FDA News Alert: FDA approves new treatment for adults with relapsed follicular lymphoma. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-treatment-adults-relapsed-follicular-lymphoma"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-0993-T"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw282"},{"key":"cit0056","first-page":"25711","volume":"10","author":"Dreyling M","year":"2019","journal-title":"Am J Hematol"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-587279"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00915"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-850461"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-016-0382-3"},{"key":"cit0061","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/annonc\/mdw320","volume":"27","author":"Vuylsteke P","year":"2016","journal-title":"Ann Oncol"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13561"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1306"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.01.024"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-017-0530-5"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2017.10.014"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30376-5"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-017-0482-9"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8808"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2225"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx289"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.4648"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.802.802"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0090"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.7107"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32201"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25072"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-802470"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020412"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.202"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2020.1791083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T09:35:07Z","timestamp":1620466507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2020.1791083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":80,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020,10,12]]}},"alternative-id":["10.1080\/14656566.2020.1791083"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2020.1791083","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}